Breakthroughs in Advanced Hormone-Sensitive Breast Cancer Treatment
Over the last 20 years, the life expectancy of patients with metastatic breast cancer has virtually tripled. Nearly half of all patients with stage IV breast cancer are living more than five years. And we have new research and treatments to thank for that.
Most women with advanced breast cancer have been treated in the past for early stage disease and are experiencing a recurrence. Many of these patients don’t realize that treating advanced breast cancer is a lot different than what they experienced their first time around. In fact, some of the newest therapies came out so recently that they might not have even been available when the patient was first receiving treatment.
Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced
or reprinted without permission from Healthgrades Operating Company, Inc. Use
of this information is governed by the Healthgrades User Agreement.